Niki Georgatou
- Co-authors
- Spiros MiyakisDemetrios�� SpandidosIrini MavrouAthanasios G. KaditisGeorge P. StathopoulosEleni KostadimaSotirios TsiodrasEmmanouel Ι. Alexopoulos
- Topics
- Lung Cancer Research Studies (8 papers)Lung Cancer Treatments and Mutations (6 papers)Cancer Treatment and Pharmacology (3 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Niki Georgatou
13 papers receiving 341 citations
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 183
- Oncology 108
- Molecular Biology 100
- Physiology 79
- Biomaterials 59
Countries citing papers authored by Niki Georgatou
This map shows the geographic impact of Niki Georgatou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niki Georgatou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niki Georgatou more than expected).
Fields of papers citing papers by Niki Georgatou
This network shows the impact of papers produced by Niki Georgatou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niki Georgatou. The network helps show where Niki Georgatou may publish in the future.
Co-authorship network of co-authors of Niki Georgatou
This figure shows the co-authorship network connecting the top 25 collaborators of Niki Georgatou. A scholar is included among the top collaborators of Niki Georgatou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niki Georgatou. Niki Georgatou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 90 | |
| 4 | 13 | |
| 5 | Pegylated Liposomal Doxorubicin HCL (Caelyx) in combination with Sandostatin LAR as salvage therapy in patients with small-cell lung cancer. | 2 |
| 6 | Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study. | 4 |
| 7 | 12 | |
| 8 | Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer. | 5 |
| 9 | 50 | |
| 10 | 75 | |
| 11 | 36 | |
| 12 | Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II study. | 5 |
| 13 | 57 |
About Niki Georgatou
Niki Georgatou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology, having authored 13 papers that have together received 358 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (183 citations), Biomaterials (59 citations) and Oncology (108 citations). Niki Georgatou has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Spiros Miyakis, Demetrios�� Spandidos, Irini Mavrou, Athanasios G. Kaditis, George P. Stathopoulos, Eleni Kostadima, Sotirios Tsiodras, Emmanouel Ι. Alexopoulos, D. Antoniou and J. Dimitroulis. Their work appears in journals such as Scientific Reports, CHEST Journal and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.